Logo image of LMAO

LMF ACQUISITION OPPORTUNIT-A (LMAO) Stock Fundamental Analysis

NASDAQ:LMAO - Nasdaq - US5020151008 - Common Stock - Currency: USD

12.35  +1.46 (+13.41%)

After market: 13.5 +1.15 (+9.31%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to LMAO. LMAO was compared to 0 industry peers in the Unkown industry. No worries on liquidiy or solvency for LMAO as it has an excellent financial health rating, but there are worries on the profitability. LMAO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year LMAO was profitable.
LMAO had a negative operating cash flow in the past year.
LMAO Yearly Net Income VS EBIT VS OCF VS FCFLMAO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 0 -200K -400K -600K -800K -1M

1.2 Ratios

Industry RankSector Rank
ROA 3.7%
ROE 3.98%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LMAO Yearly ROA, ROE, ROICLMAO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 0 -5 -10 -15 -20 -25

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LMAO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LMAO Yearly Profit, Operating, Gross MarginsLMAO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021

7

2. Health

2.1 Basic Checks

Compared to 1 year ago, LMAO has about the same amount of shares outstanding.
LMAO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LMAO Yearly Shares OutstandingLMAO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2M 4M 6M 8M 10M
LMAO Yearly Total Debt VS Total AssetsLMAO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 14.07 indicates that LMAO is not in any danger for bankruptcy at the moment.
There is no outstanding debt for LMAO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 14.07
ROIC/WACCN/A
WACCN/A
LMAO Yearly LT Debt VS Equity VS FCFLMAO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 14.35 indicates that LMAO has no problem at all paying its short term obligations.
A Quick Ratio of 14.35 indicates that LMAO has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 14.35
Quick Ratio 14.35
LMAO Yearly Current Assets VS Current LiabilitesLMAO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 100K 200K 300K

1

3. Growth

3.1 Past

LMAO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1635.73%, which is quite impressive.
EPS 1Y (TTM)1635.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.21%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 41.17, the valuation of LMAO can be described as expensive.
The average S&P500 Price/Earnings ratio is at 26.34. LMAO is valued rather expensively when compared to this.
Industry RankSector Rank
PE 41.17
Fwd PE N/A
LMAO Price Earnings VS Forward Price EarningsLMAO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LMAO Per share dataLMAO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for LMAO!.
Industry RankSector Rank
Dividend Yield N/A

LMF ACQUISITION OPPORTUNIT-A

NASDAQ:LMAO (10/28/2022, 8:00:01 PM)

After market: 13.5 +1.15 (+9.31%)

12.35

+1.46 (+13.41%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.01%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap161.06M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 41.17
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.63
P/tB 1.62
EV/EBITDA N/A
EPS(TTM)0.3
EY2.43%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0
BVpS7.56
TBVpS7.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.7%
ROE 3.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.35
Quick Ratio 14.35
Altman-Z 14.07
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1635.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.21%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-934.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-934.97%
OCF growth 3YN/A
OCF growth 5YN/A